Nanooptics and Nanophotonics News

RSS

Hybrid Plastics Achieves Milestone with Nanomaterials

Hybrid Plastics Achieves Milestone with Nanomaterials

Hybrid Plastics under sponsorship from The National Science Foundation, Electronics Division, has reached a milestone by producing the first conformal coating capable of suppressing tin whiskers. Lead-free electronics are ubiquitous. Consequently, so is the potential of electronic short circuits from conductive tin whiskers which grow from lead-free solder joints and interconnects.

24 Sep 2008

Detecting Protein-DNA Interactions Using Photonic Crystal Biosensors

Detecting Protein-DNA Interactions Using Photonic Crystal Biosensors

Scientists at the University of Illinois have developed a new class of disposable, microplate-based optical biosensors capable of detecting protein-DNA interactions. Based on the properties of photonic crystals, the biosensors are suitable for the rapid identification of inhibitors of protein-nucleic acid and protein-protein interactions.

24 Sep 2008

Researchers Awarded Julius Springer Prize for Pioneering Work on Nanoscale Carbon Materials

Researchers Awarded Julius Springer Prize for Pioneering Work on Nanoscale Carbon Materials

This year's Julius Springer Prize for Applied Physics will be awarded to Phaedon Avouris and Tony Heinz for their pioneering work on the electrical and optical properties of nanoscale carbon materials including carbo...

From Springer - Science and Technology Publishers 23 Sep 2008

Alberta Centre for Advanced Microsystems and Nanotechnology Appoints New CTO

ACAMP Alberta Centre for Advanced MNT (Microsystems and Nanotechnology) Products is pleased to announce the appointment of Dr. Kevin Yallup as Chief Technology Officer. In this new role Dr. Yallup will lead the product d...

23 Sep 2008

New Technology Enables Scientists to Identify Proteins Inside Cells

A new technology which enables scientists to identify proteins by making a map of the energy flow inside the protein is revealed today in Proceedings of the National Academy of Sciences (PNAS) journal. The scientists...

23 Sep 2008

Nanobiotix Announces EPO Issued Patent Protecting nanoXray Anticancer Platform

Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office (EPO) has issued Patent No. 1744789 to the Company, related to its "novel activable particles t...

From Nanobiotix 22 Sep 2008

University of Essex Awarded EU Marie Curie Fellowships to Study Injected Spin Lasers

The Department of Computing and Electronic Systems at the University of Essex has received over £120,000 for a prestigious EU Marie Curie Fellowship. The Department’s Professor Mike Adams explains: 'Th...

22 Sep 2008

Broadcom Announces Industry's First Family of 65 nm 10G Physical Layer Devices

Broadcom Corporation, a global leader in semiconductors for wired and wireless communications, today announced the industry's first family of 65 nanometer (nm) 10 Gigabit (10G) physical layer (PHY) devices that suppo...

22 Sep 2008

Low-Cost Disposable Cartridges Could Speed Up Diagnosis and Treatment

Low-cost, disposable cartridges that would let doctors perform diagnostic tests at the point-of-care could speed up diagnosis and treatment while lowering costs. European researchers are rapidly closing in on that goal. ...

21 Sep 2008

Mycelium Coated with Nanoparticles - An Approach to New Catalytic Systems

When fungi, such as penicillium, grow, they form a thread-like network, the mycelium. If the fungus is grown in a medium containing nanoscopic particles of a noble metal, the resulting mycelium is coated with the nanopar...

19 Sep 2008

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.